Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil  by Carvalho, Mariana et al.
Original Report 
Prevalence of Herpes Simplex ‘Irfrpe 2 Antibodies 
and a Clinical History of Herpes in Three Different 
Populations in Campinas City, Brazil 
Mariana Carvalho; Silva de Carvalho, MD;* Clkudio S&gio Pannuti, MD, PhD;* 
Laura Masami Sumita, BSc;” and Vanda Akico Ueda Fick de Souza, PhD* 
ARSTRAcT 
Objectives: To determine the seroprevalence of herpes simplex 
virus type 2 (HSV-2) antibodies and the relation between the 
history of clinical herpes and the presence of type-specific 
HSV-2 antibodies in three different populations from the city of 
Campinas City, Brazil. 
Population and methods: One hundred and one college students, 
96 patients with sexually transmitted diseases (STD), and 102 
women at delivery were interviewed and blood samples were col- 
lected. Total HSV (HSV-I and HSV-2) antibodies were screened 
by enzyme-linked immunosorbent assay (ELISA) and type-spe- 
cific HSV-2 antibodies were detected by Western blot assay. 
Results: Herpes simplex virus antibodies were detected in 
66.3% of the students, 97.1% of the women at delivery, and 
99.0% of the STD patients. Type-specific HSV-2 antibodies 
were detected in 6.9% of the students, 22.6% of the women 
at delivery, and in 53.1% of the STD patients. History of gen- 
ital herpes was reported by none of the students, by one of the 
women at delivery, and by 11 of 51 (21.6%) STD patients who 
were HSV-2 seropositive. Four of the 45 (8.9%) seronegative 
STD patients reported a history of genital herpes. 
Conc/usion: The prevalence of HSV-2 infection in Campinas 
City can be significantly affected by the characteristics of the 
population studied, as was shown in previous studies. The 
sensitivity of the history of genital herpes was low in the pre- 
sent series, stressing that prophylactic measures for vertical 
and horizontal transmission of HSV-2 should not be based only 
on a positive history of genital ulcers. 
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Herpes simplex virus @ISA’) type 2 is the principal cause 
of genital herpes, a life-long infection that may result in 
frequent and severe recurrent genital lesions accompa- 
nied by serious emotional and psychological problems.1-3 
Unrecognized symptomatic cases and frequent asymp- 
tomatic viral shedding are the main source of continued 
genital HSV-2 transmission. *s5 The asymptomatic shed- 
ding in the genital tract at the time of delivery is respon- 
sible for most neonatal HSV-2 infection.6-s The acquisition 
of genital herpes during pregnancy has been associated 
with spontaneous abortion, prematurity, and serious con- 
sequences in neonates born to infected women, includ- 
ing severe neurodevelopmental disabilities and death.9-12 
In addition, HSV-2 genital herpes has been considered an 
important risk factor for the acquisition of human immuno- 
deficiency virus (HIV) infection.13 
The introduction of type-specific tests for detection 
of HSV-2 antibodies allowed accurate seroepidemiologic 
studies of the HSV-2 infection.‘*-‘” The prevalence has 
been correlated with demographic and epidemiologic 
factors such as age, sex, race, ethnic group, lifetime num- 
ber of sexual partners, age at first sexual intercourse, and 
previous history of sexually transmitted diseases.17-20 
Despite the availability of diagnostic techniques and 
antiviral therapy, the incidence of HSV-2 infection is 
increasing in the world, which indicates the need of con- 
trol measures.21 
The objective of the present study was to evaluate 
the prevalence of type-specific HSV-2 antibodies and the 
relation of HSV-2 antibodies with the history of genital 
herpes in three different populations in Campinas City, 
Brazil. 
MATERIAL AND METHODS 
Study Population 
The study was conducted at the University of Campinas 
(UNICAMP), in Campinas City, Brazil, from 1993 to 1997. 
Campinas City is an industrialized city with 908,000 
inhabitants, with a mean income of US $9800 per year, 
located in the State of SPo Paulo. 
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The study was approved by the local Research and 
Ethics Committee. After informed consent had been 
signed, the participants were interviewed and had blood 
samples collected. All participants were asked about the 
degree of education, number of sexual partners in the 
previous year, and history of clinically diagnosed genital 
herpes. The following groups were enrolled in the study: 
1. 96 low-income patients, aged 14 to 57 years, 44 
female and 52 male, attending a public sexually trans- 
mitted diseases (STD) clinic. 
2. 102 women at delivery, 14 to 42 years of age, at the 
University Hospital, which serves a low income pop- 
ulation. 
3. 101 college students, 17 to 30 years of age, 41 female 
and 60 male, from UNICAMF! 
Serologic Tests 
Herpes simplex virus (HSV-l/HSV-2) antibodies were 
screened by an in-house enzyme-linked immunosorbent 
assay (ELISA) with viral antigens from pooled Vero cells 
infected with HSV-1 (McIntyre strain) and HSV-2 (John- 
son N strain) that were solubilized by sonication in phos- 
phate buffered saline (PBS), pH 7.2, containing 0.2% 
sodium deoxycholate. Control antigen was prepared with 
uninfected Vero cells. Microtiter plates (Polysorp, Nalge 
Nunc International Corporation, Rochester, NY) coated 
with HSV-1 and HSV-2 antigens were blocked with PBS 
containing 5% nonfat dry milk, 0.01% thimerosal, and 
0.1% Tween 80 (buffered saline), and a 1: 100 serum dilu- 
tion was dispensed into wells coated with either virus or 
control antigen, and incubated for 1 hour at 37°C. After 
four washes with PBS containing 0.1% Tween 80 (PBST), 
peroxidase-conjugated antihuman IgG (Gibco BRL) was 
added, and the plates were incubated for 40 minutes at 
37”CAfter four additional washes, chromogenic substrate 
containing 0.02% hydrogen peroxide and 0.05% o- 
phenylenediamine in 0.05 M sodium citrate buffer, pH 
5.0, was added. The enzymatic reaction was stopped with 
2.5 N H,SO* and absorbance was read at 492 nm. The 
results for each serum sample, expressed as AOD (dif- 
ference of optical density), were obtained by subtracting 
the absorbance of the control antigen from the 
absorbance of HSV antigen, and sera presenting AOD 0.3 
or higher were considered positive. 
Herpes simplex virus-2 type-specific antibodies were 
detected in ELISA-positive samples by Western blot analy- 
ses as described elsewhere.i6 Antigen was prepared with 
Vero cells infected with HSV-2 (Johnson N strain) 
solubilized with lysis buffer (10 mM Tris-HCI, pH 7.5, 1% 
Nonideta -P40, PMSF 1 mM). The HSV-2 antigen with 
equal volume of sample buffer (10 mM Tris, pH 6.8, 1 
mM EDTA, 8% sodium dodecyl sulfate, 20% glycerol, 5% 
2-mercaptoethanol, and 0.01% bromophenol blue) was 
boiled for 5 minutes, followed by electrophoresis in 8% 
discontinuous polyacrylamide gels with mini-Protean II 
apparatus (Bio-Rad Laboratories, Richmond, CA), and then 
transferred to nitrocellulose at 70 mA for 1 hour. The 
nitrocellulose was then cut in strips and blocked for 2 
hours with BS and incubated overnight at room temper- 
ature with 1 mL of serum sample diluted 1:50 in PBS. 
Nitrocellulose strips were washed four times for 5 min- 
utes each with PBST. After incubation with peroxidase- 
conjugated antihuman IgG (Gibco BRL) for 1 hour, the 
strips were washed four times with PBST, rinsed once 
with Tris-buffered saline (500 mM NaCl in 20 mM Tris, 
pH 7.5) (TBS), and stained for 10 minutes with chro- 
mogenic substrate (30 mg of 4-cloro-1-naphthol in 10 mL 
of cold methanol, 30 ILL of 30% H,O, and 50 mL of TBS). 
The strips were then washed with water and allowed to 
dry. Seropositivity for HSV-2 was defined by the presence 
of the 92,000-Mr band of gG-2. 
Statistical Analyses 
Chi-square and Fisher’s exact tests for proportions and 
chi-square for linear trend were applied for comparison 
of prevalence rates, using an ~~1-6 software. 
RESULTS 
Sixty-seven of the 101 (66.3%) students had total HSV 
antibodies, as detected by ELISA. This prevalence was 
low (P < 0.0001) compared with the group of women at 
delivery (97.1%) and STD patients (99.0%). The preva- 
lence of total HSV antibodies was similar in all age groups 
in the three populations. 
The overall prevalence of type-specific HSV-2 anti- 
bodies was 6.9% in the student group, 22.6% in the 
women at delivery, and 53.1% in the STD patients 
(P < 0.0001). Differing from total HSV antibodies, the 
prevalence of type-specific HSV-2 antibodies increased 
with age in the group of STD patients (P < 0.05). In the 
women at delivery the prevalence rates increased in the 
different age groups up to 30 years (P < 0.01). Unex- 
pectedly, after 30 years of age the prevalence rate 
decreased (Table 1). 
Among the students the prevalence rates of HSV-2 
antibodies were similar in males (6.7%) and females 
(7.3%), but in STD patients the rate was significantly 
higher (P < 0.05) in males (63.5%) than in females 
(40.9%). Thirty-two (61.5%) of the males reported hav- 
ing more than one sexual partner in the previous year 
compared with nine (20.5%) of female patients 
(P < 0.0001). 
When only individuals who had HSV-2 antibodies 
were considered, a history of genital herpes was reported 
by none of the seven students, by 1 of 23 (4.3%) of the 
women at delivery, and by 11 of 5 1 (21.6%) of the STD 
patients. Seven of the 11 STD patients who had a history 
of genital herpes had ulcers clinically diagnosed as genital 
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Table 1. Prevalence of HSV and Type-Specific HSV-2 Antibodies by Age Group 
Women at Delivery 
Age M HSv* HSV-2I 
5 20 33 (94.3) 4 (11.4) 
21-25 20 (95.2) 5 (23.8) 
26-30 19 (100.0) 9 (47.4) 
>30 27 (100.0) 5 (18.5) 
Total 99 (97.1) 23 (22.5) 
*ELISA; +Western blot. Note: Data are no positive (Yh). 
College Students 
HSV* HSV-2+ 
28 (70.0) 2 (5.0) 
36 (64.3) 5 (9.8) 
3 (60.0) 0 (0.0) 
(66.3) 
- 
67 7 (6.9) 
STD Pafienfs 
HSv* HSV-2’ 
17 (94.4) 7 (38.9) 
26 (100.0) 11 (42.3) 
12 (100.0) 7 (58.3) 
40 (100.0) 26 (65.0) 
95 (99.0) 51 (53.1) 
HSV infection when admitted in the study Among the 
HSV-2-negative patients, 4 of 45 (8.9%) reported a history 
of genital herpes. The sensitivity of the history of genital 
herpes in STD patients was 2 1.6% and the specificity was 
91.1% (Table 2). 
In addition, four HSV-2-negative patients had a clin- 
ical diagnosis of genital herpes when admitted to the 
study but gave no history of the disease; all four had total 
HSV antibodies detected by ELISA. 
DISCUSSION 
In the present study, the prevalence of HSV infection was 
similar in all age groups in the three populations, a find- 
ing which was somewhat expected in an almost exclu- 
sively adult study group. The two groups with a lower 
level of education (i.e., women at delivery and STD 
patients) had higher rates of HSV antibodies (97.1% and 
99.0%, respectively) than the college students (66.3%). 
In Brazil, education level correlates with socioeconomic 
status and almost all college students belong to a high 
socioeconomic level. These results are similar to those 
of studies in adult populations from developed countries, 
where HSV antibodies have been detected in 30 to 50% 
of high and 80 to 100% of low socioeconomic level 
groups. r 
In the present study, the prevalence of type-specific 
HSV-2 antibodies increased with age. However, no expla- 
nation was found for the unexpected lower prevalence 
rate of HSV-2 antibodies after 30 years of age in the group 
of women at delivery. In this group, the overall preva- 
lence (22.5%) was lower than that seen in a previous 
study, conducted in Sao Paulo in 1988, which reported 
42% and 31% prevalence rates, in the low and interme- 
diate socioeconomic classes, respectivelyzz Western blot 
Table 2. History of Genital Herpes and Seropositivity 
by Western Blot Assay in the Group of STD Patients 
Western Blot 
History of Genital Herpes Positive 
n = 96 (100%) n = 51 (700%) 
Positive 15 (15.6) 11 (21.6) 
Negative 81 (84.4) 40 (78.4) 
Negative 
n = 45 (100%) 
4 (8.9) 
41 (91.1) 
assay was used in both studies to detect HSV-2 antibodies. 
The lower prevalence rate found in the Campinas City 
study might be attributed to differences in socioeconomic 
status and sexual behavior between the two populations. 
Campinas is a city with a higher per capita income, and 
is about 15 times smaller than Sao Paulo. Changes in sex- 
ual behavior after the epidemic of acquired immuno- 
deficiency syndrome (AIDS) also might have played a role 
in the incidence of HSV-2 infections. The prevalence of 
HSV-2 antibodies in this group was similar to that found 
in studies conducted in a matched group in Europe and 
in the USA.23-25 The low prevalence of HSV-2 infection 
observed among college students (6.9%) was similar to 
that reported in American students.26~27 
Among the STD patients (all HIV-negative), 53.1% 
had HSV-2 type-specific antibodies. This prevalence is 
low compared to a study conducted in Rio de Janeiro, 
Brazil, by Rosa-Santos et aLz8 where 72% of the patients 
had HSV-2 antibodies measured by type-specific enzyme 
immunoassay (EL4). As it has been demonstrated that the 
type-specific EL4 and the Western blot assay have similar 
sensitivities,‘” the authors believe that the difference in 
HSV-2 prevalence found in these two populations could 
be explained by the inclusion of HIV-positive patients in 
the study in Rio de Janeiro. Gwanzura et al reported 
HSV-2 seroprevalence of 35.7% among HIV-negative sub- 
jects and 82.7% among HIV-positive subjects in Zim- 
babwe.29 Although the overall prevalence of HSV-2 
antibodies in the group of STD patients was similar to that 
reported in STD clinics of other countries,25x30 the higher 
seroprevalence in males was unexpected. This finding 
might be explained by a difference in sexual behavior, as 
a higher number of sexual partners was reported in the 
male group than among the females. 
The sensitivity of the history of genital herpes was 
low in the group of women at delivery and the students. 
Only one of the 23 HSV-2-seropositive women and none 
of the students had a history of genital herpes. A low sen- 
sitivity (~10%) of the history of genital herpes also was 
reported by Fleming et al in their study of a noninstitu- 
tionalized population of Americans.18 Moreover, only 11 
of 5 1 (21.6%) STD patients with antibodies to HSV-2 gave 
a history of genital herpes. These results are similar to 
findings reported in Australia, where the HSV-2 sero- 
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prevalence in STD patients was 64%, but only 24% 
reported a history of genital herpes.‘l 
The higher sensitivity of the history of genital herpes 
among the HSV-2-positive STD patients, compared to 
women at delivery and students, can be attributed to 
their awareness of the infection, since 7 of 11 patients 
who had history of genital herpes were attending the 
STD clinic for the same reason at the time of sample 
collection. 
A clinical history of genital herpes also was reported 
by 4 of 45 (8.9%) HSV-2-seronegative STD patients. This 
result suggests that genital herpes in these patients was 
caused by HSV-1, as they were all ELISA positive. A wide 
range c7-50%) of proportion of isolates of HSV-1 from 
first episodes of genital herpes has been reported in var- 
ious countries,3z but in Brazil information concerning the 
type of HSV associated with genital herpes is not avail- 
able. However, a misdiagnosis of genital herpes also could 
have occurred, since HSV culture or detection of HSV 
antigens was not performed to confirm the clinical diag- 
nosis of genital herpes. Additionally, a failure in antibody 
testing also must be considered. 
The four HSV-2-negative patients with genital ulcer 
at the time of sample collection had no history of geni- 
tal herpes. This finding could be due to a primary HSV-2 
genital infection, as it has been demonstrated that sero- 
conversion is detected by Western blot assay in only 25% 
of samples drawn earlier than 21 days from the onset of 
the disease.i6 In these cases an incorrect clinical diag- 
nosis, HSV-1 infection, or a failure in antibody testing also 
must be considered. 
CONCLUSION 
In Campinas City, the prevalence of HSV-2 infection varies 
significantly according to the characteristics of the pop- 
ulation studied. The sensitivity of the history of genital 
herpes is low, indicating that prophylactic measures for 
vertical and horizontal transmission of HSV-2 should not 
be based only on a positive history of genital ulcers. 
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